Dengue infection ranges from mild fever to life-threatening hemorrhagic shock, yet there is still no dedicated antiviral treatment, and vaccine use remains limited. Early diagnosis and accurate prediction of disease progression are paramount to improving patient outcomes. However, no reliable biomarkers for severe dengue have been identified to date. To address this gap, the Eijkman… Continue reading International Partnership to Identify Biomarkers of Severe Dengue
Month: August 2025
PvSeroTaT Workshop Highlights a Path Toward Ending Malaria in Indonesia
Indonesia has set an ambitious goal: eliminating malaria nationwide by 2030. At the Asia Pacific Leaders Malaria Alliance (APLMA) meeting in 2024, the government reaffirmed its commitment, highlighting significant progress so far. As of today, 85% of Indonesians live in malaria-free areas. Still, more than 400,000 cases are reported each year, with Plasmodium vivax (P.… Continue reading PvSeroTaT Workshop Highlights a Path Toward Ending Malaria in Indonesia
What is G6PD Deficiency?
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy in the world. G6PD is the first and rate-limiting enzyme in the pentose phosphate pathway. Individuals with G6PD deficiency have a decreased ability to produce reduced nicotinamide adenine dinucleotide phosphate (NADPH), crucial in protecting red blood cells from damage caused by free radicals. The genetic disorder… Continue reading What is G6PD Deficiency?
EHI Scientists Join Seminar on Precision Health and Genomics at RSCM
On 29 July 2025, EHI researchers Illene Nanine and Devin attended the seminar “Guest Lecture Future Scholar Spotlight: Precision Health Through Clinical and Functional Genomics”, organized by the Metabolic Disorder, Cardiovascular, and Aging Research Center (MVA) IMERI-FKUI and the Clinical Research Unit (CRU) of Dr. Cipto Mangunkusumo Hospital (RSCM). The event focused on precision medicine… Continue reading EHI Scientists Join Seminar on Precision Health and Genomics at RSCM